The influence of dopamine on semantic activation in Parkinson's disease: Evidence from a multipriming task

被引:28
|
作者
Angwin, Anthony J. [1 ]
Copland, David A.
Chenery, Helen J.
Murdoch, Bruce E.
Silburn, Peter A.
机构
[1] Univ Queensland, Ctr Res Language Proc & Linguist, Div Speech Pathol, Brisbane, Qld 4072, Australia
[2] Princess Alexandra Hosp, Dept Neurosci, Brisbane, Qld 4102, Australia
关键词
dopamine; levodopa; Parkinson's disease; semantic priming; signal-to-noise ratio;
D O I
10.1037/0894-4105.20.3.299
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Research has suggested that semantic processing deficits in Parkinson's disease (PD) are related to striatal dopamine deficiency. As an investigation of the influence of dopamine on semantic activation in PD, 7 participants with PD performed a lexical-decision task when on and off levodopa medication. Seven healthy controls matched to the participants with PD in terms of sex, age, and education also participated in the study. By use of a multipriming paradigm, whereby 2 prime words were presented prior to the target word, semantic priming effects were measured across stimulus onset asynchronies (SOAs) of 250 Ins and 1,200 Ins. The results revealed a similar pattern of priming across SOAs for the control group and the PD participants on medication. In contrast, within-group comparisons revealed that automatic semantic activation was compromised in PD participants when off medication. The implications of these results for the neuromodulatory influence of dopamine on semantic processing in PD are discussed.
引用
收藏
页码:299 / 306
页数:8
相关论文
共 50 条
  • [31] Walking while talking: A dopamine-responsive task in early Parkinson's disease
    Kwon, PS
    Verghese, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (04) : 735 - 737
  • [32] Semantic decisions in Parkinson's disease
    Riestra, AR
    Crucian, GP
    Womack, KB
    Holland, N
    Heilman, KM
    NEUROLOGY, 2002, 58 (07) : A243 - A244
  • [33] Semantic festinations in Parkinson's disease
    Biran, I
    Linetsky, E
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2005, : 208 - 208
  • [34] Dopamine transporter and Parkinson's disease
    Nakamura, S
    Kawakami, H
    Morino, H
    Kawarai, T
    Yamashita, H
    Takahashi, T
    Mitsuoka, T
    Kaseda, Y
    CATECHOLAMINE RESEARCH: FROM MOLECULAR INSIGHTS TO CLINICAL MEDICINE, 2002, 53 : 467 - 470
  • [35] Dopamine agonists for Parkinson's disease
    Sharma, J
    MacMahon, D
    Stewart, D
    LANCET, 2003, 361 (9351): : 84 - 84
  • [36] Dopamine, Parkinson's disease, and volition
    Horvitz, JC
    BEHAVIORAL AND BRAIN SCIENCES, 2002, 25 (05) : 586 - +
  • [37] Dopamine Receptors and Parkinson's Disease
    Hisahara, Shin
    Shimohama, Shun
    INTERNATIONAL JOURNAL OF MEDICINAL CHEMISTRY, 2011, 2011
  • [38] Dopamine agonists in Parkinson's disease
    Tintner, R
    Jankovic, J
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (11) : 1803 - 1820
  • [39] Intracerebroventricular dopamine for Parkinson's disease
    Devos, David
    Devedjian, Jean-Christophe
    Moreau, Caroline
    ONCOTARGET, 2017, 8 (28) : 45034 - 45035
  • [40] Extrastriatal dopamine and Parkinson's disease
    Parent, A
    Cossette, M
    PARKINSON'S DISEASE, 2001, 86 : 45 - 54